This 39th Annual Meeting includes a wide range of topics such as international drug development and collaboration, pharmacometrics, pharmacogenomics, and specific sessions concerning biologics, nutraceuticals, and drug therapy in special populations.
Keynote Speaker, Stephen P. Spielberg, M.D., Ph.D., Director, Center for Personalized Medicine & Therapeutic Innovation will address the audience on Monday morning with his presentation entitled "What the 'Developed' and 'Developing' Worlds Have Taught Each Other About Health and Therapeutics for Children".
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of the U.S. Food and Drug Administration, will be the keynote speaker on Tuesday afternoon and address "Pharmacology and Public Health at FDA".
Visit the organization's website for more information.